The Northeast Pulmonary Teaching Conference
The
American Lung Association of Central New York
and the
New
York State
Society for Respiratory Care
|
|
Jim is presently a Fellow in Respiratory Science at Aerogen, Inc. in
Sunnyvale,
CA. Jim has been
widely published in aerosol delivery systems, and has chaired the
Asthma Consortium in Chicago. His informative presentation at last year’s ALA
Teaching Day on “Bronchodilator Rescue in the ED" was well received, and we
look forward to his expertise in implementing successful community asthma
coalitions.
Jim has taken an active interest in clinical applications of aerosols, over
the last three decades. Jim has served as participating author in the AARC
Clinical Practice Guidelines on Aerosols and the more recent Consensus
Conference on Aerosols and Delivery Devices.
His research interests range from aerosol delivery during mechanical
ventilation to proper device selection and training for patients at home.
Heliox and Aerosols in the ICU
A
review of limitations of aerosol therapy as commonly administered in the ICU,
and an exploration of evidence supporting newer therapeutic approaches, with
emphasis on the role of Helium Oxygen during mechanical ventilation and
continuous nebulization.
Objectives:
 |
Discuss how heliox increases aerosol delivery but
decreases jet nebulizer output.
|
|
Identify systems for effectively delivering Heliox to
patients in the ICU.
|
|
Describe critieria for ventilator or nebulizer
selection for use with Heliox.
|
New Frontiers in Aerosol Medicine
A critical
look at technical and pharmaceutical advances that will transform aerosol
therapy over the next decade. We
will explore the evolution of aerosol generators, and devices currently in
development, and preview the array of drugs being developed for both respiratory
and systemic delivery.
Objectives:
|
Discuss how breath actuated nebulizers effect inhaled
dose and treatment times.
|
|
Describe limitations of current passive DPIs, and how
active DPIs allow consistent drug delivery despite low inspiratory flow
rates.
|
| Identify
three inhaled drugs being studied for systemic therapy |
Program
[ Home ] [ Who we are ] [ Program Committee ] [ Program ] [ 2002 Faculty ] [ Accreditation ] [ Registration ] [ Accommodations ] [ Sponsors ] |
|
For more program information, contact Glenn Ivers at the American Lung
Association of Central New York at 1620 Burnett Avenue, Syracuse, NY 13206,
tel: 315-422-6142
e-mail:
Russ Acevedo, Program Chair and Webmaster:
Glenn Ivers, Co-Chair:
Chuck Svoboda, Co-Chair:
|
| |